HomeProductsBioactive CompoundsAnti-Infective AgentsHCVNesbuvir
Chemical structure of CAS 691852-58-1

Nesbuvir

CAS No.691852-58-1
MDL No.MFCD22208574
MFC22H23FN2O5S
MW446.50
InChI KeyWTDWVLJJJOTABN-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.691852-58-1
Product NameNesbuvir

Associated Conditions

hepatitis C virus infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase.

The Journal of biological chemistry • Vol. 285, Issue 18 • 2010
PMID: 20194503PMC: PMC2859531DOI: 10.1074/jbc.M109.082206

Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides.

Bioorganic & medicinal chemistry letters • Vol. 20, Issue 7 • 2010
PMID: 20219368DOI: 10.1016/j.bmcl.2010.02.054

The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors.

The Journal of infectious diseases • Vol. 202, Issue 1 • 2010
PMID: 20486856PMC: PMC3008401DOI: 10.1086/653080

Substituted imidazopyridines as potent inhibitors of HCV replication.

Journal of hepatology • Vol. 50, Issue 5 • 2009
PMID: 19303654PMC: PMC7114863DOI: 10.1016/j.jhep.2008.12.028

Documentation

Similar Products